Basic Info.
Model NO.
|
2023788-19-2
|
Colour
|
White
|
Name
|
Tirzepatide
|
Packing
|
10vials/Kit
|
Other Name
|
GLP-1, Tirzepatide, Semaglutide,Retatrutide
|
Shipping Weight
|
90grams/Kit
|
Transport Package
|
Box
|
Purity
|
99%
|
Trademark
|
Oumeina
|
Origin
|
Wuhan
|
Production Capacity
|
1000boxes Per Day
|
|
|
Product Description
Muscle Rebuilding Tirzepatide Raw Peptide Powder 2mg/10mg/15mg CAS 2023788-19-2
We also supply other peptides, roids raw powder, injection oil, oral pills.
Welcome to send an inquiry to get more information.
I will reply you in half an hour.
Semaglutide & Trizepatide
GLP-1 agonists
were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called
Semaglutide & Tirzepatide
.
BENEFITS OF GLP-1 AGONISTS
-
Helps slow food leaving your stomach
-
Helps prevent your liver from making too much sugar
-
Helps the pancreas produce more insul when your blood sugar levels are high
-
Can help control blood glucose
-
Can reduce hyperglycemia, especially after meals
-
Can reduce fasting insul and fasting glucose
-
Can reduce hemoglobin A1c
-
Can decrease appetite and caloric intake, while inhibiting weight gain
-
Has been shown to lower triglyceride levels and oxidative stress from high LDL
-
Has been shown to help induce weight loss in obese patients with higher dosing
-
Helps decrease leptin and increase leptin sensitivity
-
Can increase the conversion of white fat to brown fat
Semaglutide is
indicated
as an adjunct to diet and exercise to improve
glycemic control
in adults with type
2 diabetes.
The higher-dose formulation of semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with
obesity
(initial
body mass index
(BMI) ≥ 30 kg/m
2
) or who are overweight (initial BMI ≥ 27 kg/m
2
) and have at least one weight-related
comorbidity
.
A review of anti-obesity treatments found that semaglutide as well as
tirzepatide
(which has an overlapping mechanism of action) were more promising than previous anti-obesity drugs, although less effective than
bariatric surgery
.
There is evidence, primarily from animal studies, that semaglutide also reduces non-food cravings, such as for alcohol.
Orders from Customers
Shipping and Payment
Our Promise To You:
-
Every product we sell is 100 %Authentic & Top Quality.
-
Your Satisfaction is 100% Guaranteed or your money back.
Shipping:
-
UK Overnight Delivery.
-
Express and Expedite Shipping Available